BMO Capital Starts Abbvie (ABBV) at Outperform; Well-Positioned to Manage Humira's LOE
Tweet Send to a Friend
(Updated - November 18, 2020 6:54 AM EST)BMO Capital analyst Gary Nachman initiates coverage on Abbvie (NYSE: ABBV) with an ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
